Table 4.
Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Evaluation MELD-XI | 1.32 | 1.08–1.61 | 0.01 | |||
Evaluation albumin | 0.54 | 0.17–1.72 | 0.30 | |||
Evaluation liver risk score | 1.06 | 1.02–1.1 | 0.01 | 1.08 | 1.01–1.15 | 0.02 |
Abnormal liver sonogram (fibrosis or cirrhosis) | 2.80 | 0.29–26.6 | 0.37 | |||
Fibrosis on liver biopsy | ||||||
Fibrosis 0–2 | Reference | |||||
Fibrosis > 2–4 | 7.43 | 0.59–94.3 | 0.12 | |||
VAD pre-HTx | 2.80 | 0.57–13.8 | 0.21 | |||
Pre-operative MELD–XI | 1.87 | 1.16–3.03 | 0.01 | 2.22 | 1.04–4.75 | 0.04 |
Pre-operative albumin | 0.37 | 0.12–1.18 | 0.09 | |||
Pre-operative liver risk score | 1.10 | 1.03–1.19 | 0.01 | |||
Improved MELD-XI (evaluation to HTx) | 0.90 | 0.79–1.03 | 0.13 |
CI, confidence interval; HTx, heart transplantation; MELD-XI, Model of End-stage Liver Dysfunction eXcluding International normalized ratio; OR, odds ratio; VAD, ventricular assist device.